Skip to main content Skip to site footer

You are using an outdated browser. Please upgrade your browser to improve your experience.

Sarah Ackland

Head of Architas UK Funds
Sarah has been at Architas since 2014 and was promoted from head of UK proposition to head of Architas UK funds in September 2017. Sarah has responsibility for all commercial aspects of the UK business including distribution, proposition and business development.

Before joining Architas Sarah spent the previous seven years as a sales director at Thomas River Capital and then F&C after its acquisition. Sarah previously worked in an offshore role for Friends Provident International as manager of the funds marketing and research team with responsibility for its international funds range. She has a Bachelor of Arts degree from Liverpool Hope University and holds the Investment Management Certificate. 

THIS WEEK

Latest insights from our team

Our market view

Article | Investments | 06/05/2020

Given the unprecedented situation and current high levels of volatility in the world economy, markets are clamouring for a conclusion to Covid-19.

Spotlight on Covid-19

Article | Investments | 06/05/2020

There is a lot of uncertainty surrounding the outcome of the global pandemic. While comparisons to previous downturns are difficult given the uniqueness of this situation, looking at historical events may help to provide perspective and maybe a bit of hope to all of the gloom.

Protection against market falls

Article | Investments | 05/05/2020

Today’s Covid-19-driven declines are clearly concerning, but markets inevitably have downswings as well as upswings and we’ve seen drops of this level before. So how can we provide some potential fund protection and position ourselves for any potential rebound?

We use cookies to give you the best possible experience of our website. If you continue, we'll assume you are happy for your web browser to receive all cookies from our website. See our cookie policy for more information on cookies and how to manage them.